Cargando…
Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection
Intra-abdominal thromboses are a poorly characterised thrombotic complication of COVID-19 and are illustrated in this case. A 42-year-old man with chronic hepatitis B (undetectable viral load, FibroScan 7.4 kPa) developed fever and cough in March 2020. 14 days later, he developed right upper quadran...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757448/ https://www.ncbi.nlm.nih.gov/pubmed/33371000 http://dx.doi.org/10.1136/bcr-2020-238906 |
_version_ | 1783626751907201024 |
---|---|
author | Abeysekera, Kushala WM Karteszi, Hedvig Clark, Amanda Gordon, Fiona H |
author_facet | Abeysekera, Kushala WM Karteszi, Hedvig Clark, Amanda Gordon, Fiona H |
author_sort | Abeysekera, Kushala WM |
collection | PubMed |
description | Intra-abdominal thromboses are a poorly characterised thrombotic complication of COVID-19 and are illustrated in this case. A 42-year-old man with chronic hepatitis B (undetectable viral load, FibroScan 7.4 kPa) developed fever and cough in March 2020. 14 days later, he developed right upper quadrant pain. After being discharged with reassurance, he re-presented with worsening pain on symptom day 25. Subsequent abdominal ultrasound suggested portal vein thrombosis. CT of the abdomen confirmed portal and mid-superior mesenteric vein thromboses. Concurrent CT of the chest suggested COVID-19 infection. While reverse transcription PCR was negative, subsequent antibody serology was positive. Thrombophilia screen excluded inherited and acquired thrombophilia. Having been commenced on apixaban 5 mg two times per day, he is currently asymptomatic. This is the first case of COVID-19-related portomesenteric thrombosis described in the UK. A recent meta-analysis suggests 9.2% of COVID-19 cases develop abdominal pain. Threshold for performing abdominal imaging must be lower to avoid this reversible complication. |
format | Online Article Text |
id | pubmed-7757448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-77574482020-12-28 Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection Abeysekera, Kushala WM Karteszi, Hedvig Clark, Amanda Gordon, Fiona H BMJ Case Rep Case Report Intra-abdominal thromboses are a poorly characterised thrombotic complication of COVID-19 and are illustrated in this case. A 42-year-old man with chronic hepatitis B (undetectable viral load, FibroScan 7.4 kPa) developed fever and cough in March 2020. 14 days later, he developed right upper quadrant pain. After being discharged with reassurance, he re-presented with worsening pain on symptom day 25. Subsequent abdominal ultrasound suggested portal vein thrombosis. CT of the abdomen confirmed portal and mid-superior mesenteric vein thromboses. Concurrent CT of the chest suggested COVID-19 infection. While reverse transcription PCR was negative, subsequent antibody serology was positive. Thrombophilia screen excluded inherited and acquired thrombophilia. Having been commenced on apixaban 5 mg two times per day, he is currently asymptomatic. This is the first case of COVID-19-related portomesenteric thrombosis described in the UK. A recent meta-analysis suggests 9.2% of COVID-19 cases develop abdominal pain. Threshold for performing abdominal imaging must be lower to avoid this reversible complication. BMJ Publishing Group 2020-12-22 /pmc/articles/PMC7757448/ /pubmed/33371000 http://dx.doi.org/10.1136/bcr-2020-238906 Text en © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage |
spellingShingle | Case Report Abeysekera, Kushala WM Karteszi, Hedvig Clark, Amanda Gordon, Fiona H Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection |
title | Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection |
title_full | Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection |
title_fullStr | Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection |
title_full_unstemmed | Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection |
title_short | Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection |
title_sort | spontaneous portomesenteric thrombosis in a non-cirrhotic patient with sars-cov-2 infection |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757448/ https://www.ncbi.nlm.nih.gov/pubmed/33371000 http://dx.doi.org/10.1136/bcr-2020-238906 |
work_keys_str_mv | AT abeysekerakushalawm spontaneousportomesentericthrombosisinanoncirrhoticpatientwithsarscov2infection AT karteszihedvig spontaneousportomesentericthrombosisinanoncirrhoticpatientwithsarscov2infection AT clarkamanda spontaneousportomesentericthrombosisinanoncirrhoticpatientwithsarscov2infection AT gordonfionah spontaneousportomesentericthrombosisinanoncirrhoticpatientwithsarscov2infection |